Literature DB >> 31139855

Association between objective sleep duration and bone mineral density in older postmenopausal women from the Study of Osteoporotic Fractures (SOF).

C M Swanson1, P J Blatchford2, E S Orwoll3, J A Cauley4, E S LeBlanc5, H A Fink6, K P Wright7,8, M E Wierman7,9, W M Kohrt10, K L Stone11,12.   

Abstract

Methodological limitations preclude determination of the association between sleep duration and bone mineral density (BMD) from existing literature. This was the first study to use objective sleep duration to determine its association with BMD. Nocturnal sleep duration, assessed objectively (actigraphy) or subjectively (questionnaire), was not independently associated with BMD in postmenopausal women.
INTRODUCTION: Both long and short self-reported sleep durations are associated with low bone mineral density (BMD) in men and women. The association between sleep duration measured by actigraphy and BMD in postmenopausal women is unknown.
METHODS: The Study of Osteoporotic Fractures (SOF) ancillary sleep study was used to determine the association between sleep duration and BMD at the total hip and femoral neck in postmenopausal women ≥ 75 years old. Sleep duration was assessed by wrist actigraphy (average 4 nights) and questionnaire. BMD was compared between postmenopausal women with short (< 6 h/night) vs. NIH-recommended (7-8 h/night) sleep durations. Data were analyzed using a 2-sample t test (unadjusted) and multivariate regression model (adjusted). Simple linear regression was used to estimate the difference in BMD per additional hour of sleep when sleep duration was considered as a continuous, rather than dichotomized, variable.
RESULTS: Total hip BMD was higher in women with actigraphically assessed shorter sleep duration in unadjusted models only. No clinically or statistically significant differences in total hip or femoral neck BMD were observed according to nocturnal sleep duration after adjusting for body mass index (BMI) in dichotomized (N = 874) or continuous (N = 1624) sleep duration models or when subjective sleep duration was used. When sleep duration included daytime naps, longer sleep duration was associated with lower total hip BMD (β = - 0.005, p = 0.04).
CONCLUSIONS: Nocturnal sleep duration, whether assessed objectively (actigraphy) or subjectively (questionnaire), was not independently associated with BMD in older postmenopausal women.

Entities:  

Keywords:  Actigraphy; Bone mineral density (BMD); Postmenopausal women; Sleep duration

Mesh:

Year:  2019        PMID: 31139855      PMCID: PMC6800619          DOI: 10.1007/s00198-019-05007-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  5 in total

1.  Self-reported sleep characteristics and risk for incident vertebral and hip fracture in women.

Authors:  Tianyi Huang; Susan Redline; Catherine M Gordon; Eva Schernhammer; Gary C Curhan; Julie M Paik
Journal:  Sleep Health       Date:  2022-02-28

2.  Bone Turnover Markers After Six Nights of Insufficient Sleep and Subsequent Recovery Sleep in Healthy Men.

Authors:  Christine M Swanson; Prajakta Shanbhag; Emma J Tussey; Corey A Rynders; Kenneth P Wright; Wendy M Kohrt
Journal:  Calcif Tissue Int       Date:  2022-02-08       Impact factor: 4.000

Review 3.  Sleep disruptions and bone health: what do we know so far?

Authors:  Christine M Swanson
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2021-08-01       Impact factor: 3.626

4.  Sleep duration and bone health measures in older men.

Authors:  W M Kohrt; E S Orwoll; C M Swanson; P J Blatchford; K L Stone; J A Cauley; N E Lane; T S Rogers-Soeder; S Redline; D C Bauer; K P Wright; M E Wierman
Journal:  Osteoporos Int       Date:  2020-09-15       Impact factor: 4.507

5.  Bone turnover marker responses to sleep restriction and weekend recovery sleep.

Authors:  Christopher M Depner; John D Rice; Emma J Tussey; Robert H Eckel; Bryan C Bergman; Janine A Higgins; Edward L Melanson; Wendy M Kohrt; Kenneth P Wright; Christine M Swanson
Journal:  Bone       Date:  2021-06-30       Impact factor: 4.398

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.